Buffalo Business & Estate Services Ltd. Acquires Amgen Shares

Firm adds $5.4 million stake in medical research company

Apr. 6, 2026 at 8:34am

Got story updates? Submit your updates here. ›

Buffalo Business & Estate Services Ltd. acquired a new position in Amgen Inc. (NASDAQ:AMGN) during the fourth quarter, according to a recent SEC filing. The firm purchased 16,716 shares of the medical research company's stock, valued at approximately $5,471,000. Amgen now accounts for around 0.8% of Buffalo Business & Estate Services Ltd.'s investment portfolio.

Why it matters

This transaction reflects growing institutional investor interest in Amgen, a leading biopharmaceutical firm known for its innovative therapies. As Amgen continues to expand its drug pipeline and navigate industry challenges, the company's stock performance and fundamentals will be closely watched by the investment community.

The details

Buffalo Business & Estate Services Ltd. added the Amgen shares to its portfolio in the fourth quarter of the previous fiscal year. The firm's new position in Amgen represents approximately 0.8% of its total assets under management. Amgen is a major player in the biotechnology industry, developing and commercializing a range of medicines to treat serious illnesses.

The new Amgen position was established in Q4 of the previous fiscal year.
The SEC filing disclosing the transaction was published on April 6, 2026.

The players